Bill SniderPartner
Bill leads the firm’s growth capital investing activities.
VIEW FULL BIO
D. Kyle Wilson Partner
Kyle leads the firm’s M&A advisory activities and has 25 years of investment banking experience.
Tim Johnson Partner
Tim has over 25 years of combined private equity, investment banking and financial advisory experience.
Lars Hanan Partner
Lars has executed over 100 transactions in a broad range of industries.
Robert WickeOperating Partner
Robert helps lead the technical due diligence of the firm’s capital investing activities.
Anup Parikh Operating Partner
Anup helps lead the firm’s capital investing activities focused on companies within the molecular biology and software segments.
Aaron Goldman Operating Partner
Aaron is an Operating Partner at BroadOak where he supports the firm’s investing activities, diligence, and portfolio companies.
Holly Atallah Director of Finance & Operations
Holly has two decades of investment banking, hedge fund investing and corporate development experience.
Austin Duke Managing Director
Austin leads and supports BroadOak’s venture capital and early-stage investments.
Michael Caspani Managing Director
Michael helps lead evaluation, execution, and portfolio management efforts for the firm’s debt and equity investments.
Matt McFarland Managing Director
Matt leads the firm’s pharma services M&A advisory practice and has over 15 years of investment banking experience.
Daniel Friedman Principal
Daniel specializes in portfolio management and investment execution as part of BroadOak’s growth capital investing team.
Pete Corish Vice President of BD, Europe
Pete helps expand access to BroadOak’s expertise, capabilities and services in Europe.
Elliot Frumkin Director of Investor Relations
Elliot cultivates relationships with BroadOak’s Limited Partners.
Royal Donigan Analyst
Royal provides M&A transaction support to BroadOak’s Advisory team, including coordination, modeling.
Henry Dervishi Associate
Henry specializes in portfolio management and investment execution as part of BroadOak’s growth capital investing team.
Max WeisAssociate
Max Weis specializes in portfolio management and investment execution as part of BroadOak’s growth capital investing team.
Our team is focused on helping life sciences companies realize their full potential. Dan Friedman Vice President
Now that you've gotten to know us, reach out. We'd like to hear from you.